Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus (Q37420759)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus |
scientific article published on April 2004 |
Statements
Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus (English)
1 reference
James B Mahony
1 reference
Astrid Petrich
1 reference
Lisa Louie
1 reference
Xinyu Song
1 reference
Sylvia Chong
1 reference
Marek Smieja
1 reference
Max Chernesky
1 reference
Mark Loeb
1 reference
Susan Richardson
1 reference
Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections
1 reference
1 reference
Identifiers
1 reference